These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32548871)

  • 1. Assessment of clinical inertia in people with diabetes within primary care.
    Meredith AH; Buatois EM; Krenz JR; Walroth T; Shenk M; Triboletti JS; Pence L; Gonzalvo JD
    J Eval Clin Pract; 2021 Apr; 27(2):365-370. PubMed ID: 32548871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical inertia among health care providers in a public health safety-net clinic in the management of type 2 diabetes.
    Lingow SE; Guyton JE
    J Am Pharm Assoc (2003); 2020; 60(5):734-739. PubMed ID: 32280024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist Impact on Treatment Intensification and Hemoglobin A
    Cowart K; Sando K
    J Pharm Pract; 2019 Dec; 32(6):648-654. PubMed ID: 29768945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a pharmacist-led diabetes management service in an endocrinology clinic.
    Parsiani R; Lundy R; Ahmann A; Joarder F; Castle J
    J Am Pharm Assoc (2003); 2022; 62(6):1855-1859. PubMed ID: 36089458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
    Khunti K; Nikolajsen A; Thorsted BL; Andersen M; Davies MJ; Paul SK
    Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Pharmacist and Physician Collaboration in the Treatment of Type 2 Diabetes Mellitus With Severe Insulin Resistance Using U-500 Insulin.
    Hess R; Brandon S; Johnson F
    South Med J; 2016 Nov; 109(11):690-693. PubMed ID: 27812708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.
    Ampudia-Blasco FJ; Palanca A; Trillo JL; Navarro J; Real JT
    J Diabetes Complications; 2021 Mar; 35(3):107828. PubMed ID: 33436143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of Pharmacist-Physician Collaborative Care on Therapeutic Inertia in Patients With Type 2 Diabetes.
    Cowart K; Emechebe N; Pathak R; Abbruzese L; Hann J; Lloyd A; Roetzheim R; Zgibor J; Updike WH
    Ann Pharmacother; 2022 Feb; 56(2):155-161. PubMed ID: 34105397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [INERTIA study: Clinical inertia in non-insulinized patients on oral hypoglycemic treatment. A study in Spanish primary and specialty care settings].
    González-Clemente JM; Font B; Lahoz R; Llauradó G; Gambús G;
    Med Clin (Barc); 2014 Jun; 142(11):478-84. PubMed ID: 23622897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
    Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
    Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Effect of Pharmacist Care on Diabetes-Related Outcomes in a Rural Outpatient Clinic: A Retrospective Case-Control Study.
    Moreau C; Sando KR; Zambrano DH
    Ann Pharmacother; 2017 Jun; 51(6):473-478. PubMed ID: 28064508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensification patterns and the probability of HbA
    Pantalone KM; Misra-Hebert AD; Hobbs TM; Ji X; Kong SX; Milinovich A; Weng W; Bauman JM; Ganguly R; Burguera B; Kattan MW; Zimmerman RS
    Diabet Med; 2020 Jul; 37(7):1114-1124. PubMed ID: 30653705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the change in glycated hemoglobin for patients in an employee health program formerly managed by a pharmacist-run ambulatory care clinic.
    Bou-Ghazale L; Oldham E; Bundeff AW; Hwang AY
    Am J Health Syst Pharm; 2023 Oct; 80(21):1564-1569. PubMed ID: 37486825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting.
    Canivell S; Mata-Cases M; Real J; Franch-Nadal J; Vlacho B; Khunti K; Gratacòs M; Mauricio D
    Diabetes Obes Metab; 2019 Jun; 21(6):1373-1380. PubMed ID: 30756446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical inertia in basal insulin-treated patients with type 2 diabetes - Results from a retrospective database study in Japan (JDDM 43).
    Satoh J; Andersen M; Bekker Hansen B; Larsen Thorsted B; Tutkunkardas D; Zacho M; Maegawa H
    PLoS One; 2018; 13(9):e0198160. PubMed ID: 30226870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Clinical Pharmacist Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes in a Rural Setting.
    Sullivan J; Jett BP; Cradick M; Zuber J
    Ann Pharmacother; 2016 Dec; 50(12):1023-1027. PubMed ID: 27497068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic.
    Irons BK; Lenz RJ; Anderson SL; Wharton BL; Habeger B; Anderson HG
    Pharmacotherapy; 2002 Oct; 22(10):1294-300. PubMed ID: 12389879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
    Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
    Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTING.
    Lin J; Zhou S; Wei W; Pan C; Lingohr-Smith M; Levin P
    Endocr Pract; 2016 Feb; 22(2):151-61. PubMed ID: 26492540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.